Clinical Trials
7 trialsNCT02573324 2023-05-11
Intellance1
AbbVie
Phase 3 Completed
NCT03419403 2021-04-14
UNITE Study: Understanding New Interventions With GBM ThErapy
AbbVie
Phase 3 Terminated
NCT02590263 2020-09-03
Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma
AbbVie
Phase 1/2 Completed
NCT02343406 2020-05-22
INTELLANCE-2
AbbVie
Phase 2 Completed
NCT03123952 2019-07-15
Expanded Access to ABT-414
AbbVie
No longer available
NCT01800695 2017-11-21
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
AbbVie
Phase 1 Completed
NCT01741727 2017-11-20
A Study of ABT-414 in Subjects With Solid Tumors
AbbVie
Phase 1 Completed